Professor Simon Finfer, of The George Institute for Global Health, led investigators in this second study, which provided an important new analysis of the Normoglycemia in Intensive Care Evaluation–Survival Using Glucose Algorithm Regulation (NICE SUGAR) trial data.
Despite and perhaps because of the advances in biomedicine over the past few decades, chronic diseases, like heart disease, stroke, and diabetes are now rising in many places of the world and more worryingly they impose their heaviest burden on the poor and disadvantaged populations.
In 2002, 3.5 million people died of cancer in Asia. This is expected to increase to 8.1 million by 2020. As the death rate and prevalence of cancer hits hard in Asia, specific concerns have been raised about the economic toll of the disease on patients and their families. Ongoing treatments are expensive and can impose a considerable financial burden.
One quarter of the world’s adult population suffers from hypertension, and although it has no obvious symptoms, it can lead to heart attacks, stroke, kidney failure and blindness. Despite this, there has been great uncertainty as to how intensively blood pressure should be lowered to obtain maximal benefit and minimize risks.
Professor Chris Maher, Director of the Musculoskeletal Division at The George Institute for Global Health, said that the new back pain tool — Back Pain Choices — synthesises recommendations from evidence-based practice guidelines in Australia, the UK and USA into a unified set of recommendations.
The ADVANCE study assessed over 10,000 people living with type 2 diabetes across 20 countries. The study has identified the benefits of tight blood pressure and blood glucose control for people with diabetes, and has influenced guidelines for diabetes care globally.
Mary Anne Land joined The George Institute for Global Health in 2010. Not even 12 months after completing her Masters in Public Health in her hometown of Wollongong NSW, she now finds herself completing an internship at The World Health Organization (WHO) in Geneva.